Skip to main content

Table 3 Summary of immunohistochemical staining

From: Molecular portrait-based correlation between primary canine mammary tumor and its lymph node metastasis: possible prognostic-predictive models and/or stronghold for specific treatments?

SAMPLES ID

PRIMARY MAMMARY TUMOR

LYMPH NODE METASTASIS

 

ER*

PR*

c-erbB-2°

CK 14*

CK 5/6*

p63*

ER*

PR*

c-erbB-2°

CK 14*

CK 5/6*

p63*

1

1

1

1

1

1

0

0

1

1

1

1

0

2

0

1

1

1

1

0

0

1

1

1

1

0

3

1

0

1

1

1

1

0

0

0

0

0

0

4

0

0

1

1

1

0

0

0

1

1

1

0

5

0

1

3

1

1

1

0

1

3

1

1

0

6

1

0

1

1

1

1

0

0

1

1

1

1

7

1

1

1

1

1

1

1

1

0

1

1

0

8

0

1

1

1

1

0

0

0

1

1

1

0

9

1

1

3

1

1

1

0

0

3

1

1

0

10

1

1

3

1

1

1

1

1

3

1

1

0

11

0

0

1

1

0

0

0

0

1

1

0

0

12

1

0

2

1

1

1

0

0

1

1

1

0

13

1

0

2

1

1

1

0

0

1

0

0

0

14

1

1

1

1

1

0

1

0

1

1

1

0

15

0

0

2

1

1

0

0

0

3

1

1

0

16

1

0

1

1

1

0

1

0

1

0

1

0

17

0

1

2

1

1

0

0

1

2

1

1

0

18

0

0

2

1

1

1

0

0

2

0

0

0

19

0

0

1

1

1

0

0

0

1

1

1

0

20

0

1

2

1

1

1

0

0

2

1

1

1

  1. *ER, PR, CK5/6, CK14, p63: 0= no immunoreactivity; 1= immunoreactivity. °c-erbB-2: 0= no immunoreactivity; 1= <10% positive cells; 2= 10 to 90% complete membranous immunostaining; 3= >90% complete membranous cell positivity.